Form 13-F position report

IMMUNOVANT INC WT EXP Call options

Reported by K2 PRINCIPAL FUND L P

Company profile Manager portfolio Source filing
IMVTW CUSIP 45258J110 Manager CIK 0001461790
Latest reported change

Reported 0 underlying shares controlled, down 127,100 (100.0%) from the prior quarter.

Reported value -100.0%; share count -100.0% vs. the prior quarter.

Reduced
% of reported 13F value 0 This manager · Q2 2020
Underlying shares 0 Quarter-end amount reported
Reported notional value $0 Underlying-share value; not option premium
Consecutive quarters held 2 Through Q2 2020

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Manager history

Quarterly position history

How this manager's reported quarter-end position changed over time.

0 quarters
Quarter Activity Underlying shares Change % of reported 13F Reported notional value Filed
This position's reported history falls outside the five-year preview window. A free account unlocks it. Unlock full history
Institutional context

Who else reported the position

1 manager reported IMMUNOVANT INC WT EXP for Q2 2020.

Manager Activity Underlying shares Change % of reported 13F Reported notional value Tenure
K2 PRINCIPAL FUND L P This report Reduced 0 -127,100 0 $0 2 qtrs
A free account expands this comparison to 25 managers. Create free account
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
June 30, 2020
Filed
August 13, 2020
Filing type
13F-HR
Position type
Call options

Voting authority reported

No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.